Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7353432

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
54,685,000,000 JPY
72,984,000,000 JPY
55,573,000,000 JPY
Ordinary profit (loss)
9,304,000,000 JPY
8,727,000,000 JPY
12,976,000,000 JPY
Net assets
140,137,000,000 JPY
136,836,000,000 JPY
140,704,000,000 JPY
Total assets
168,337,000,000 JPY
166,328,000,000 JPY
167,767,000,000 JPY
Basic earnings (loss) per share
177.10
68.85
144.80
243.31
84.99
Diluted earnings per share
Equity-to-asset ratio
0.832 xbrli:pure
0.819 xbrli:pure
0.835 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.